Kidney Disease

Lower baseline eGFR was identified as a major risk factor for adverse drug reactions in patients with chronic kidney disease, according to a recently published data.

A high BMI in late adolescence — even a high-normal BMI — was associated with increased odds of early chronic kidney disease in young adulthood, according to a study published in JAMA Pediatrics.

Patients with type 2 diabetes and chronic kidney disease receiving empagliflozin were less likely to experience a decline in eGFR compared with patients taking placebo, results from a newly published study show.

Healio has compiled a list of its most-read chronic kidney disease care news in 2023.

Healio has compiled a list of its most-read news items regarding AKI in 2023.

Nearly three-quarters of individuals with sickle cell disease are not using disease-modifying therapies in their treatment, according to a study published in JAMA Network Open.

The use of finenerone to reduce albuminuria in patients with chronic kidney disease and type 2 diabetes provided kidney and cardiovascular benefits when the urine albumin-to-creatine ratio was reduced by 30% or more, a study shows.

Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.

Community-acquired AKI is a common entity associated with serious adverse clinical outcomes during the 6-month period after diagnosis, according to a recently published study.